What will we see in diabetes in the next 10 years?
作者信息
Bloomgarden Zachary T
机构信息
Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
出版信息
J Diabetes. 2024 Jun;16(6):e13594. doi: 10.1111/1753-0407.13594.
Abstract
摘要
相似文献
1
What will we see in diabetes in the next 10 years?未来10年我们在糖尿病领域将会看到什么？
J Diabetes. 2024 Jun;16(6):e13594. doi: 10.1111/1753-0407.13594.
2
IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.国际糖尿病联盟糖尿病地图集：2011 年和 2030 年全球糖尿病患病率估计。
Diabetes Res Clin Pract. 2011 Dec;94(3):311-21. doi: 10.1016/j.diabres.2011.10.029. Epub 2011 Nov 12.
3
Implications of population growth on prevalence of diabetes. A look at the future.人口增长对糖尿病患病率的影响。展望未来。
Diabetes Care. 1992 Mar;15 Suppl 1:6-9. doi: 10.2337/diacare.15.1.s6.
4
Long-Term Exposure to Road Traffic Noise and Incidence of Diabetes in the Danish Nurse Cohort.长期暴露于道路交通噪声与丹麦护士队列中糖尿病的发生率。
Environ Health Perspect. 2019 May;127(5):57006. doi: 10.1289/EHP4389.
5
Diabetes cases could double in developing countries in next 30 years.未来30年，发展中国家的糖尿病病例可能会翻倍。
Cent Eur J Public Health. 2004 Mar;12(1):25.
6
[Diabetes mellitus].
Ned Tijdschr Tandheelkd. 2012 Feb;119(2):65-71. doi: 10.5177/ntvt.2012.02.11253.
7
[Diabetes mellitus in the next decade].
Z Arztl Fortbild Qualitatssich. 2002 Mar;96(3):153.
8
[Post-transplantation diabetes mellitus in kidney recipients].
Nephrol Ther. 2017 Apr;13 Suppl 1:S137-S146. doi: 10.1016/j.nephro.2017.01.011.
9
The Asian Association for the Study of Diabetes: The first 10 years and the next 10 years.亚洲糖尿病研究协会：过去 10 年和未来 10 年。
J Diabetes Investig. 2020 Sep;11(5):1079-1084. doi: 10.1111/jdi.13353. Epub 2020 Aug 16.
10
Diabetes Mellitus in Outpatients in Debre Berhan Referral Hospital, Ethiopia.埃塞俄比亚德布雷伯尔汉转诊医院门诊患者中的糖尿病
J Diabetes Res. 2016;2016:3571368. doi: 10.1155/2016/3571368. Epub 2016 Jan 6.
引用本文的文献
1
The effect of peer support on HbA1c levels in middle-aged and elderly patients with type 2 diabetes: a systematic review and meta-analysis.同伴支持对中老年2型糖尿病患者糖化血红蛋白水平的影响：一项系统评价与Meta分析
PeerJ. 2025 Aug 28;13:e19803. doi: 10.7717/peerj.19803. eCollection 2025.
本文引用的文献
1
Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91).一项2型糖尿病强化血糖控制随机对照试验的试验后监测，时间从10年延长至24年（英国前瞻性糖尿病研究91）
Lancet. 2024 Jul 13;404(10448):145-155. doi: 10.1016/S0140-6736(24)00537-3. Epub 2024 May 18.
2
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria.估计 2 型糖尿病合并白蛋白尿患者接受 SGLT2 抑制剂、GLP-1 受体激动剂和非甾体类 MRA 联合治疗与常规治疗相比的终生心血管、肾脏和死亡率获益。
Circulation. 2024 Feb 6;149(6):450-462. doi: 10.1161/CIRCULATIONAHA.123.067584. Epub 2023 Nov 12.
3
Obesity, diabetes, and cancer: epidemiology, pathophysiology, and potential interventions.肥胖、糖尿病和癌症：流行病学、病理生理学和潜在干预措施。
Arch Endocrinol Metab. 2023 Jun 19;67(6):e000647. doi: 10.20945/2359-3997000000647.
4
Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates.基于 2020 年人口普查估计数的美国心血管疾病预测。
J Am Coll Cardiol. 2022 Aug 9;80(6):565-578. doi: 10.1016/j.jacc.2022.05.033.
5
Projecting National-Level Prevalence of General Obesity and Abdominal Obesity Among Chinese Adults With Aging Effects.预测中国成年人因老龄化效应而导致的全国性普通肥胖和腹型肥胖的患病率。
Front Endocrinol (Lausanne). 2022 Mar 8;13:849392. doi: 10.3389/fendo.2022.849392. eCollection 2022.
6
Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.在患有 2 型糖尿病和动脉粥样硬化性心血管疾病的患者中使用降脂、降压和降糖药物治疗。
JAMA Netw Open. 2022 Feb 1;5(2):e2148030. doi: 10.1001/jamanetworkopen.2021.48030.
7
Projecting the Incidence of Type 2 Diabetes-Related End-Stage Kidney Disease Until 2040: A Comparison Between the Effects of Diabetes Prevention and the Effects of Diabetes Treatment.预测 2040 年之前与 2 型糖尿病相关的终末期肾病发病率：糖尿病预防与糖尿病治疗效果的比较。
Diabetes Care. 2021 Jul;44(7):1515-1523. doi: 10.2337/dc21-0220. Epub 2021 May 23.
8
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis.全球糖尿病视网膜病变的患病率及 2045 年预期负担的系统评价和荟萃分析。
Ophthalmology. 2021 Nov;128(11):1580-1591. doi: 10.1016/j.ophtha.2021.04.027. Epub 2021 May 1.
9
Beyond 2020: Modelling obesity and diabetes prevalence.超越 2020 年：肥胖和糖尿病患病率建模。
Diabetes Res Clin Pract. 2020 Sep;167:108362. doi: 10.1016/j.diabres.2020.108362. Epub 2020 Aug 3.
10
Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity.预计美国各州成年人肥胖和重度肥胖的流行率。
N Engl J Med. 2019 Dec 19;381(25):2440-2450. doi: 10.1056/NEJMsa1909301.
Zotero 插件